Filter Options | ||||||
---|---|---|---|---|---|---|
Public title |
Verify status |
Pay status |
||||
Study ailment |
Study type |
Study phase |
||||
Applicant |
Study leader |
Primary sponsor |
||||
Countries of recruitment and research settings |
|
|||||
More Options |
Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
---|---|---|---|---|---|---|---|
ChiCTR2000036447 |
Zhongshan Hospital, Fudan University |
Mediastinal Tumor |
Therapy Study |
Premarket |
2025-01-15 | 296 | Patient list |
B2022-409R |
Zhongshan Hospital, Fudan University |
|
Therapy Study |
Premarket |
2022-12-27 | 809 | Patient list |
ChiCTR2100044209 |
Zhongshan Hospital, Fudan University |
|
Prognostic Study |
Premarket |
2021-03-09 | 1605 | Patient list |
ChiCTR1900023611 |
Zhongshan Hospital, Fudan University |
nonalcoholic fatty liver disease |
Therapy Study |
Premarket |
2019-06-04 | 1238 | Patient list |
ChiCTR1900020545 |
Zhongshan Hospital, Fudan University |
|
Therapy Study |
Premarket |
2019-01-07 | 1064 | Patient list |
ChiCTR1800014966 |
Zhongshan Hospital, Fudan University |
|
Therapy Study |
Premarket |
2018-02-25 | 1238 | Patient list |
ChiCTR-IPR-17011365 |
Rebound pain after single shot nerve block with ropivacaine with dexamethasone Zhongshan Hospital, Fudan University |
|
Diagnostic Accuracy Test |
Post-market |
2017-05-11 | 1287 | Patient list |
ChiCTR-IOR-15006961 |
Zhongshan Hospital, Fudan University |
end stage renal disease |
Therapy Study |
Post-market |
2015-08-24 | 929 | Patient list |
ChiCTR-OPN-15006864 |
Zhongshan Hospital, Fudan University |
lung cancer |
Therapy Study |
Post-market |
2015-08-03 | 828 | Patient list |